Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Mark S. Lesney

    News

    Reviewing the state of HCV and HBV in children

    Author:
    Mark S. Lesney
    Publish date: November 6, 2018

    HCV and HBV in children have unique characteristics coupled to a high risk of liver damage and progression to...

    • Read More

    News

    HIV superinfection: No boost to broadly neutralizing antibodies

    Author:
    Mark S. Lesney
    Publish date: November 1, 2018

    HIV superinfection does not lead to broadly neutralizing antibodies, indicating constraints on sequential...

    • Read More

    News

    Smoking neglected in patients with PAD

    Author:
    Mark S. Lesney
    Publish date: October 30, 2018

    The majority of patients with PAD are or were smokers; they rarely receive cessation interventions and...

    • Read More

    News

    Frailty tied to higher mortality after major vascular surgery

    Author:
    Mark S. Lesney
    Publish date: October 27, 2018

    Frailty was associated with increased short- and long-term mortality in surgery for lower extremity arterial...

    • Read More

    News

    Claudication, CLI differ significantly in hospital readmission, costs, mortality

    Author:
    Mark S. Lesney
    Publish date: October 24, 2018

    CLI differs significantly from claudication in costs of admission and readmission, as well as in LOS, days to...

    • Read More

    News

    HCV, HBV, and HIV associated with autoimmune kidney diseases

    Author:
    Mark S. Lesney
    Publish date: October 23, 2018

    Reviewers discuss the causal mechanisms, clinical presentations, and treatment of autoimmune kidney diseases...

    • Read More

    News

    Synthetic HCV glycoproteins elicit narrow, but not widely effective antibodies

    Author:
    Mark S. Lesney
    Publish date: October 22, 2018

    Two glycoproteins induced antibodies that neutralized some HCV strains representing genotype 1, but not strains...

    • Read More

    News

    HCV adapts to HIV coinfection

    Author:
    Mark S. Lesney
    Publish date: October 22, 2018

    A small but statistically significant variance in intrahost HVR1 was strongly associated with HCV monoinfection...

    • Read More

    News

    Pay attention to kidney disease risk in people living with HIV

    Author:
    Mark S. Lesney
    Publish date: October 18, 2018

    The reported prevalence of CKD in PLWH ranged from 2.3% to 53.3%, with the African population having the highest...

    • Read More

    News

    HIV testing low in U.S. women engaged in risky behavior

    Author:
    Mark S. Lesney
    Publish date: October 18, 2018

    HIV testing rates were especially low among women who reported having anal sex.

    • Read More

    News

    Six PAD diagnostic tests vary widely in patients with diabetes

    Author:
    Mark S. Lesney
    Publish date: October 16, 2018

    The highest percent of patients found to have PAD was 93%, detected by Doppler Waveform; the least percentage...

    • Read More

    News

    Obesity tied to improved inpatient survival of patients with PAD

    Author:
    Mark S. Lesney
    Publish date: October 16, 2018

    The obesity survival paradox was seen in a study of more than 5.6 million inpatients treated for peripheral...

    • Read More

    News

    Lower-limb atherosclerosis predicts long-term mortality in patients with PAD

    Author:
    Mark S. Lesney
    Publish date: October 16, 2018

    The location and extent of infrainguinal atherosclerosis determined by duplex ultrasound predicts long-term...

    • Read More

    News

    Novel recombinant vaccine protects animals from Lassa fever

    Author:
    Mark S. Lesney
    Publish date: October 14, 2018

    A novel recombinant Lassa virus vaccine protected guinea pigs and mice against Lassa fever.

    • Read More

    News

    Treating cryptococcal meningitis in patients with HIV

    Author:
    Mark S. Lesney
    Publish date: October 12, 2018

    One week of AmBd- and 5FC-based therapy, followed by fluconazole, appeared superior to other regimens for treating HIV-associated cryptococcal...

    • Read More

    Pages

    • « first
    • …
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • 15
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery